Trypanosoma cruzi: Antibody Production and T Cell Response Induced by Stage-Specific Surface Glycoproteins Purified from Metacyclic Trypomastigotes

1993 ◽  
Vol 77 (4) ◽  
pp. 405-413 ◽  
Author(s):  
N. Yoshida ◽  
J.E. Araya ◽  
J.F. Dasilveira ◽  
S. Giorgio
2020 ◽  
Vol 108 (4) ◽  
pp. 1239-1251
Author(s):  
Julia Barbalho da Mota ◽  
Juliana Echevarria‐Lima ◽  
Fernanda Kyle‐Cezar ◽  
Matheus Melo ◽  
Maria Bellio ◽  
...  

2011 ◽  
Vol 79 (8) ◽  
pp. 3397-3406 ◽  
Author(s):  
Matthew H. Collins ◽  
Julie M. Craft ◽  
Juan M. Bustamante ◽  
Rick L. Tarleton

ABSTRACTTrypanosoma cruziinfects millions of people in Latin America and often leads to the development of Chagas disease.T. cruziinfection can be acquired at or near the bite site of the triatomine vector, butper osinfection is also a well-documented mode of transmission, as evidenced by recent microepidemics of acute Chagas disease attributed to the consumption of parasite-contaminated foods and liquids. It would also be convenient to deliver vaccines forT. cruziby the oral route, particularly live parasite vaccines intended for the immunization of reservoir hosts. For these reasons, we were interested in better understanding immunity toT. cruzifollowing oral infection or oral vaccination, knowing that the route of infection and site of antigen encounter can have substantial effects on the ensuing immune response. Here, we show that the route of infection does not alter the ability ofT. cruzito establish infection in muscle tissue nor does it impair the generation of a robust CD8+T cell response. Importantly, oral vaccination with attenuated parasites provides protection against wild-type (WT)T. cruzichallenge. These results strongly support the development of whole-organism-based vaccines targeting reservoir species as a means to alleviate the burden of Chagas disease in affected regions.


Blood ◽  
2003 ◽  
Vol 101 (2) ◽  
pp. 621-623 ◽  
Author(s):  
Masataka Kuwana ◽  
Yutaka Kawakami ◽  
Yasuo Ikeda

The potential immunosuppressive effect of an anti-CD154 monoclonal antibody (mAb) on the pathogenic autoreactive T-cell response was evaluated using an in vitro culture system with glycoprotein IIb/IIIa (GPIIb/IIIa)–reactive T cells from patients with immune thrombocytopenic purpura (ITP). The anti-CD154 mAb did not inhibit T-cell proliferation, but suppressed anti-GPIIb/IIIa antibody production, in bulk peripheral blood mononuclear cell cultures stimulated with GPIIb/IIIa. Repeated antigenic stimulation of GPIIb/IIIa-reactive CD4+ T-cell lines in the presence of anti-CD154 mAb resulted in the loss of proliferative capacity and helper function for promoting anti-GPIIb/IIIa antibody production. These anergic T-cell lines showed a cytokine profile of low interferon γ and high interleukin 10 and suppressed anti-GPIIb/IIIa antibody production. Our results indicate that blockade of the CD40/CD154 interaction induces generation of autoantigen-specific anergic CD4+ T cells with regulatory function and could be a therapeutic option for suppressing pathogenic autoimmune responses in patients with ITP.


Author(s):  
Arnold Awuah ◽  
Ava Zamani ◽  
Fariba Tahami ◽  
Mark Davis ◽  
Louis Grandjean ◽  
...  

Abstract Understanding the T cell response to SARS-CoV-2 is key in patients who lack antibody production. We demonstrate the applicability of a functional assay to measure the T cell response in a cohort of patients with immunodeficiency.


2020 ◽  
Author(s):  
Ran Jia ◽  
Xiangshi Wang ◽  
Pengcheng Liu ◽  
Xiaozhen Liang ◽  
Yanling Ge ◽  
...  

2017 ◽  
Vol 8 ◽  
Author(s):  
Melisa Gorosito Serrán ◽  
Jimena Tosello Boari ◽  
Facundo Fiocca Vernengo ◽  
Cristian G. Beccaría ◽  
María C. Ramello ◽  
...  

Author(s):  
Paola Lasso ◽  
Jose Mateus ◽  
John Mario González ◽  
Adriana Cuéllar ◽  
Concepción Puerta

2006 ◽  
Vol 74 (4) ◽  
pp. 2477-2481 ◽  
Author(s):  
Fanny Tzelepis ◽  
Bruna C. G. de Alencar ◽  
Marcus L. O. Penido ◽  
Ricardo T. Gazzinelli ◽  
Pedro M. Persechini ◽  
...  

ABSTRACT The kinetics of effector CD8+-T-cell responses to specific Trypanosoma cruzi epitopes was investigated after challenge. Our results suggest that the delayed kinetics differs from that observed in other microbial infections and facilitates the establishment of the disease in naïve mice. In contrast, in vaccinated mice, the swift CD8+-T-cell response helps host survival after challenge.


Sign in / Sign up

Export Citation Format

Share Document